Patent details

92993 Product Name: Briviact

Basic Information

Publication number:
92993
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP040078784
Legal Status:
Active
Application number:
92993
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
22/06/2023
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
17/01/2025
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1073/001-022 - Briviact -brivaracétam
Marketing Authorization Type:
Marketing Authorization Date:
18/01/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
11/03/2016
First Marketing Authorization date:
18/01/2016
Grant date:
11/05/2016
Activation date:
21/02/2021
Publication date:
11/05/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/02/2026
SPC Extension Expiration:
21/08/2026
Rejection date:
Withdrawal date:

Owner

From:
09/08/2023
 
 

Name:
UCB BIOPHARMA SRL
Address:
Allée de la Recherche 60, 1070, Brussels, Belgium (BE)

History of Owners

From:
11/03/2016
To:
09/08/2023

Name:
UCB BIOPHARMA SPRL
Address:
ALLEE DE LA RECHERCHE 60, 1070, BRUXELLES, Belgium (BE)

Agent

Name:
ARONOVA S.A.
From:
11/03/2016
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
Michel Philippe
Address:
Belgium (BE)

2

Name:
Differding Edmond
Address:
Belgium (BE)

3

Name:
Lallemand Bénédicte
Address:
Belgium (BE)

4

Name:
Talaga Patrice
Address:
Belgium (BE)

5

Name:
Kenda Benoît
Address:
Belgium (BE)

6

Name:
Matagne Alain
Address:
Belgium (BE)

7

Name:
Pasau Patrick
Address:
Belgium (BE)

Publication

Bulletin

1

Bulletin Heading:
SPC3
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
CO
Bulletin edition number:
2023/10
Publication date:
04/09/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

4

Bulletin Heading:
SPCX2
Bulletin edition number:
2025/02
Publication date:
06/02/2025
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20230000355A
Date Registered:
09/08/2023
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
ARONOVA S.A.
Journal Edition Number:
Text:
Change of name
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
UCB BIOPHARMA SRL
Address:
Allée de la Recherche 60, 1070, Brussels, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
17/02/2025
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
CPA GLOBAL THE IP PLATFORM